Listen Aphasia Pilot Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDana-Farber Cancer Institute
About this trial
This is a feasibility and pilot study to refine and test LISTEN, an AI-based augmentative and alternative communication (AAC) smartphone app, integrated into the patient's personal electronic device, to augment and facilitate communication in patients with tumor-related aphasia (TRA) and their care partners. The study will assess the feasibility and acceptability of LISTEN in patients with TRA and their care partners.
Eligibility criteria
Qualifiers
A histologically or cytologically confirmed primary or secondary brain tumor with expected ongoing deterioration in language as determined by their oncologist
Mild-to-moderate aphasia or other acquired communication disorder as determined by their oncologist or speech-language pathologist
ECOG Performance Status of ≤2 or Karnofsky Performance Status ≥60
Expected overall survival of >6 months
Disqualifiers
Unable to read or respond to questions in English
Severe dysarthria as determined by their oncologist
Aphasia that is moderate-to-sever enough that the patient cannot consent without a proxy
Expected survival of ≤ 6 months
Trial design
Treatments tested in this trial
- LISTEN (AI-based AAC smartphone app)
Treatment groups
80 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov